McKesson Corporation MCK

Competitive advantage analysis · healthcare

Corporate Default
Overall moat score
75/100
Moderate

About McKesson Corporation

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other … Full MCK analysis →

Competitive advantage assessment

Key strengths

  • Margins Stable Across Cycles Operating margin volatility is low (stability score 0.90), demonstrating pricing resilience across cycles.
  • ROIC Sustainably Above Peers ROIC at 100.0th percentile exceeds peers and WACC, demonstrating superior capital allocation.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Moderate
72

Where MCK ranks in Medical Distribution

McKesson Corporation ranks #1 of 12 scored companies in Medical Distribution by moat score — the top 8%. That makes it the widest moat in the group.

Moat scores for companies ranked near MCK in Medical Distribution
# Company Moat score Rating
1 McKesson Corporation MCK 75/100 Moderate
2 Henry Schein, Inc. HSIC 72/100 Moderate
3 Cardinal Health, Inc. CAH 66/100 Moderate
4 Cencora, Inc. COR 60/100 Moderate
5 Zynex, Inc. ZYXI 59/100 Moderate
6 Owens & Minor, Inc. OMI 52/100 Moderate
7 111, Inc. YI 47/100 Developing
8 EDAP TMS S.A. EDAP 32/100 Developing
9 Synergy CHC Corp. SNYR 30/100 Developing

See every General Corporate company ranked by moat score →

How MCK scores on the Corporate Default defenses

Pricing Power

Score 72 · 20% of the moat score

Pricing power is the ability to raise prices without losing volume.

Cost Advantage

Score 90 · 15% of the moat score

A cost advantage means delivering the same product for structurally less — better purchasing, denser distribution, a more automated process.

Customer Stickiness

Score 77 · 15% of the moat score

Stickiness is what makes revenue repeat without being re-won every year.

Capital Efficiency

Score 78 · 18% of the moat score

Capital efficiency asks what the company earns on the money tied up in the business.

Resilience

Score 62 · 17% of the moat score

Resilience is the capacity to get through a bad year on its own terms — enough liquidity, enough interest cover, and enough cash generation to avoid a rescue financing or a forced sale.

Scale & Market Position

Score 72 · 15% of the moat score

Scale matters only when it converts into economics.

How each Corporate Default defense is measured, in full →

Understanding MCK's moat

What is McKesson Corporation's moat score?

McKesson Corporation (MCK) scores 75 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as moderate. It ranks #1 of 12 scored companies in Medical Distribution, the top 8%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 11 companies in Medical Distribution. Its strongest defense is Cost Advantage (90/100) and its weakest is Resilience (62/100).

How does McKesson Corporation compare with other Medical Distribution companies?

McKesson Corporation ranks #1 of 12 scored companies in Medical Distribution by moat score. That is the widest moat in Medical Distribution. The companies ranked closest are Henry Schein, Inc. (HSIC) at 72 just below it.

How is the moat score calculated?

Each company is scored with an industry-specific template — Corporate Default in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 11 companies in Medical Distribution. The defenses are then weighted to produce the overall score out of 100.

Why is McKesson Corporation scored with the Corporate Default template?

Most public companies sell a product or a service at a margin, so the moat question is whether that margin survives contact with competitors. The Corporate template scores the six defenses that show up in a general operating company's financial signature: whether it can hold price, produce more cheaply than rivals, keep its customers, earn a return above its cost of capital, withstand a downturn, and turn size into economics.

Which competitive defenses are measured for McKesson Corporation?

The Corporate Default template measures 6 defenses, and MCK scores: Pricing Power (72), Cost Advantage (90), Customer Stickiness (77), Capital Efficiency (78), Resilience (62), Scale & Market Position (72). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.

Send Feedback
Please select a category.
0/1000